IE40893B1 - 1-oxo-1h-6-substituted pyrimido(1,2-a)quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents - Google Patents
1-oxo-1h-6-substituted pyrimido(1,2-a)quinoline-2-carboxylic acids and derivatives thereof as antiallergy agentsInfo
- Publication number
- IE40893B1 IE40893B1 IE711/75A IE71175A IE40893B1 IE 40893 B1 IE40893 B1 IE 40893B1 IE 711/75 A IE711/75 A IE 711/75A IE 71175 A IE71175 A IE 71175A IE 40893 B1 IE40893 B1 IE 40893B1
- Authority
- IE
- Ireland
- Prior art keywords
- hydroxy
- alkoxy
- quinoline
- oxo
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45679774A | 1974-04-01 | 1974-04-01 | |
| US54722775A | 1975-02-05 | 1975-02-05 | |
| US55496675A | 1975-03-03 | 1975-03-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE40893L IE40893L (en) | 1975-10-01 |
| IE40893B1 true IE40893B1 (en) | 1979-09-12 |
Family
ID=27412681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE711/75A IE40893B1 (en) | 1974-04-01 | 1975-04-02 | 1-oxo-1h-6-substituted pyrimido(1,2-a)quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents |
Country Status (14)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4075343A (en) * | 1976-09-13 | 1978-02-21 | Pfizer Inc. | Anti-allergenic 5-alkoxyimidazo[1,2-A]quinoline-2-carboxylic acids and derivatives thereof |
| US4127720A (en) * | 1977-09-21 | 1978-11-28 | Bristol-Myers Company | Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity |
| US4209620A (en) * | 1978-06-19 | 1980-06-24 | Bristol-Myers Company | Substituted 3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives having antiallergy activity |
| US4472401A (en) * | 1981-11-27 | 1984-09-18 | Roussel Uclaf | Pyrimido-quinoxalines having antiallergic properties |
| US4510143A (en) * | 1982-02-17 | 1985-04-09 | Roussel Uclaf | Antiallergic pyrimido[1,2-a]quinoxalin-2-carboxylic acid derivatives |
| AU5533996A (en) * | 1996-04-04 | 1997-10-29 | University Of Nebraska Board Of Regents | Synthetic triple helix-forming compounds |
| US6989392B2 (en) | 2002-06-18 | 2006-01-24 | Abbott Laboratories | 2-Aminoquinolines as melanin concentrating hormone receptor antagonists |
-
1975
- 1975-03-17 CA CA222,180A patent/CA1033731A/en not_active Expired
- 1975-03-18 IL IL46864A patent/IL46864A0/xx unknown
- 1975-03-24 PH PH16958A patent/PH10464A/en unknown
- 1975-03-25 FI FI750891A patent/FI750891A/fi not_active Application Discontinuation
- 1975-03-26 DE DE19752513930 patent/DE2513930A1/de not_active Ceased
- 1975-03-26 DK DK130475AA patent/DK138743B/da not_active IP Right Cessation
- 1975-03-27 GB GB1305575A patent/GB1451423A/en not_active Expired
- 1975-03-27 NL NL7503692A patent/NL7503692A/xx not_active Application Discontinuation
- 1975-03-31 ES ES436155A patent/ES436155A1/es not_active Expired
- 1975-04-01 LU LU72184A patent/LU72184A1/xx unknown
- 1975-04-01 DD DD185117A patent/DD119425A5/xx unknown
- 1975-04-01 JP JP4022375A patent/JPS5427360B2/ja not_active Expired
- 1975-04-01 FR FR7510140A patent/FR2265389B1/fr not_active Expired
- 1975-04-02 IE IE711/75A patent/IE40893B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES436155A1 (es) | 1977-02-01 |
| DD119425A5 (US20020128544A1-20020912-P00008.png) | 1976-04-20 |
| DK138743B (da) | 1978-10-23 |
| IE40893L (en) | 1975-10-01 |
| FR2265389B1 (US20020128544A1-20020912-P00008.png) | 1978-07-28 |
| AU7937775A (en) | 1976-09-23 |
| LU72184A1 (US20020128544A1-20020912-P00008.png) | 1976-03-02 |
| DK138743C (US20020128544A1-20020912-P00008.png) | 1979-04-02 |
| NL7503692A (nl) | 1975-10-03 |
| CA1033731A (en) | 1978-06-27 |
| FI750891A (US20020128544A1-20020912-P00008.png) | 1975-10-02 |
| JPS5427360B2 (US20020128544A1-20020912-P00008.png) | 1979-09-10 |
| GB1451423A (en) | 1976-10-06 |
| DK130475A (US20020128544A1-20020912-P00008.png) | 1975-10-02 |
| JPS50140499A (US20020128544A1-20020912-P00008.png) | 1975-11-11 |
| PH10464A (en) | 1977-04-25 |
| IL46864A0 (en) | 1975-05-22 |
| DE2513930A1 (de) | 1975-10-02 |
| FR2265389A1 (US20020128544A1-20020912-P00008.png) | 1975-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8204739A1 (es) | Un procedimiento para preparar compuestos de cefem | |
| AU528275B2 (en) | Imidazole derivatives | |
| AU552322B2 (en) | Substituted imidazoles | |
| AU552908B2 (en) | 4 n-phenyl benzyl-aminomethyl-imidazole | |
| IE40893B1 (en) | 1-oxo-1h-6-substituted pyrimido(1,2-a)quinoline-2-carboxylic acids and derivatives thereof as antiallergy agents | |
| IE41822L (en) | Hydroxyalkyl xanthine derivatives | |
| EP0066909A3 (en) | Imidazole derivatives, pharmaceutical compositions containing them and processes for their production | |
| IE39269B1 (en) | Pharmaceutical compositions comprising nitrocarbostyrils for the treatment of allergic and immunological hypersensitivity | |
| ES8300755A1 (es) | Procedimiento para la preparacion de derivados de imidazol | |
| GB1504683A (en) | Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives | |
| GB1477996A (en) | Quinolizine derivatives and their preparation | |
| GB1457254A (en) | 1-phenoxy-2-hydroxy-3-chromonyloxy-propane derivatives | |
| IE39587L (en) | Antibacterial composition | |
| GB1488412A (en) | Imidazo(1,2-a)quinolines | |
| GB1509778A (en) | Pharmaceutical composition and dosage units thereof | |
| GB1528738A (en) | Isoquinolines and their preparation | |
| IE37317L (en) | Heterocyclic substituted isoprenoid compounds | |
| GB1395518A (en) | Benzodiazocine derivatives | |
| GB1530067A (en) | 3-m-hydroxyphenyl-1-propyl-3-pyrrolidine ethanol |